Influence of Pancreatic Transection With CUSA on Postoperative Pancreatic Fistula Incidence (PANCUT)
NCT ID: NCT06135012
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2023-07-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study design: A randomized controlled, single centre trial.
Study population: Two groups of 80 patients (160 in total) scheduled for elective open pancreaticoduodenectomy (PD) for any indication.
Intervention: Transection of pancreatic tissue with CUSA.
Control: Standard transection of pancreatic tissue with surgical scalpel (in PD) or stapler (in DP)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EUS Guided Drainage of Post Pancreatitis Pancreatic Fluid Collection
NCT06280248
Acute Pancreatitis and Acute Fluid Collections
NCT00786929
METabolomic and Immune PROfiling in the Development of Pancreatic Fistulas After cepHalic duodEnopancreatectomy
NCT06283160
Comparison Between Two Methods of Pancreatic Transection in Distal Pancreatectomy
NCT03880773
Randomized Controlled Trial Comparing Closed-suction Drain Versus Passive Gravity Drain Following Pancreatic Resection
NCT01988519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To compare transection of pancreatic tissue with CUSA and selective closure of small blood vessels and branch pancreatic ducts with transection with surgical scalpel or stapler in elective pancreatic resections regarding the incidence of POPF.
Study design: A randomized controlled, single centre trial. The study protocol was designed according to the SPIRIT guidelines.
Study population: Two groups of 80 patients (160 in total) scheduled for elective open pancreaticoduodenectomy (PD) for any indication.
Intervention: Transection of pancreatic tissue with CUSA.
Control: Standard transection of pancreatic tissue with surgical scalpel (in PD).
Main study parameters/endpoints: Primary outcome is the incidence of POPF. Main secondary outcomes are intraoperative outcomes (such as blood loss and operative time), postoperative outcomes (such as complications, time to functional recovery and hospital stay).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transection with CUSA
Transection of pancreatic tissue using cavitron ultrasonic surgical aspirator (CUSA) and using metal clips for closing small intraparenchymal blood vessels and pancreatic branch ducts.
Cavitron ultrasonic surgical aspirator (CUSA)
Transection of pancreatic tissue with cavitron ultrasonic surgical aspirator (CUSA).
Transection with scalpel/stapler
Standard transection of pancreatic tissue with a surgical scalpel without selective closure of small blood vessels and branch pancreatic ducts (in pancreaticoduodenectomy).
Scalpel
Transection of pancreatic tissue with scalpel.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cavitron ultrasonic surgical aspirator (CUSA)
Transection of pancreatic tissue with cavitron ultrasonic surgical aspirator (CUSA).
Scalpel
Transection of pancreatic tissue with scalpel.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients capable of understanding the provided information about the study
* Patients with signed informed consent
* Planned elective pancreaticoduodenectomy for any indication
Exclusion Criteria
* Patient incapable of understanding the provided information about the study
* Pregnancy
* Previous surgical procedures on pancreas
* Immunosuppressive therapy
* Preoperative radiotherapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Centre Ljubljana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Badovinac
Role: PRINCIPAL_INVESTIGATOR
Department of Abdominal Surgery, University Medical Centre Ljubljana
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Centre Ljubljana
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hadzialjevic B, Zavrtanik Carni H, Petric M, Dokic M, Trotovsek B, Tomazic A, Badovinac D. Influence of pancreas transection with cavitron ultrasonic surgical aspirator (CUSA) on incidence of postoperative pancreatic fistula after pancreatoduodenectomy (PANCUT): study protocol for a randomised controlled trial. Trials. 2025 Jun 4;26(1):190. doi: 10.1186/s13063-025-08898-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20230052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.